Back
ARK Innovation ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
97
ARKK
ARK Innovation ETF
Last Price:
$73.30
Seasonality Move:
-2.01%
Sell
37
APLS
Apellis Pharmaceuticals
Last Price:
$19.32
Seasonality Move:
-16.64%
Buy
97
ARK Innovation ETF (ARKK)
is a Buy
Is ARK Innovation ETF a Buy, Sell or Hold?
-
The current ARK Innovation ETF [ARKK] share price is $72.37. The Score for ARKK is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
-
ARKK is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.21. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKK Stock Price Chart
What is ARK Innovation ETF's stock price today?
-
The ARK Innovation ETF share price today is $72.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARKK is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.37 | Buy |
Relative Strength Index (14 RSI): | 71 | Buy |
Chaikin Money Flow: | 8120019 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.47 - 70.85) | Buy |
Bollinger Bands (100): | (47.82 - 64.04) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 57.88 | Buy |
Chaikin Money Flow: | 3142813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.69 - 19.09) | Buy |
Bollinger Bands (100): | (17.14 - 24.36) | Sell |
ARKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.56 | Buy |
20-day SMA: | 67.91 | Buy |
50-day SMA: | 60.3 | Buy |
200-day SMA: | 55.29 | Buy |
8-day EMA: | 70.58 | Buy |
20-day EMA: | 67.73 | Buy |
50-day EMA: | 62.23 | Buy |
200-day EMA: | 55.41 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.9 | Buy |
20-day SMA: | 18.23 | Buy |
50-day SMA: | 18.18 | Buy |
200-day SMA: | 25.58 | Sell |
8-day EMA: | 18.16 | Buy |
20-day EMA: | 18.15 | Buy |
50-day EMA: | 18.77 | Buy |
200-day EMA: | 25.96 | Sell |
ARK Innovation ETF Earnings Growth & ARKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.23 per share, and an increase next year of $0.73 per share.
ARK Innovation ETF Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |